In the world of rare diseases, progress can often feel like a slow and agonizing slog. In many cases, this is the unfortunate reality. However, a lot can change in a year, and several diseases major progress being made. One such disease was pulmonary arterial hypertension. We have selected five stories from 2019 that touch on the latest in pulmonary arterial hypertension research and treatment.
[one_half]
[/one_half] [one_half_last]
Safety Data Looks Good in Phase 3 Trial of Potential Pulmonary Arterial Hypertension Drug
[/one_half_last] [one_half]
[/one_half] [one_half_last]
Extension Trial Finds That Orenitram Improves Walking Distance in Pulmonary Arterial Hypertension
[/one_half_last] [one_half]
[/one_half] [one_half_last]
An Experimental Treatment for Pulmonary Arterial Hypertension Just Earned Orphan Drug DesignationLadies with POTS: Here Are 5 Fashion Accessories for the Holiday Season
[/one_half_last] [one_half]
[/one_half] [one_half_last]
FDA Announces Label Expansion for Treprostinil to Treat Pulmonary Arterial Hypertension Consider Rare Disease Families at Holiday Time
[/one_half_last] [one_half]
[/one_half] [one_half_last]
The Impacts of Pulmonary Arterial Hypertension Outside of the Lungs
[/one_half_last] [one_half]
